| Activating RNAs associate with Mediator to enhance chromatin architecture and transcription F Lai, UA Orom, M Cesaroni, M Beringer, DJ Taatjes, GA Blobel, ... Nature 494 (7438), 497-501, 2013 | 953 | 2013 |
| Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive E Guccione, C Bassi, F Casadio, F Martinato, M Cesaroni, H Schuchlautz, ... Nature 449 (7164), 933-937, 2007 | 557 | 2007 |
| Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response C Gorrini, M Squatrito, C Luise, N Syed, D Perna, L Wark, F Martinato, ... Nature 448 (7157), 1063-1067, 2007 | 387 | 2007 |
| Genome-wide mapping of human DNA-replication origins: levels of transcription at ORC1 sites regulate origin selection and replication timing GI Dellino, D Cittaro, R Piccioni, L Luzi, S Banfi, S Segalla, M Cesaroni, ... Genome research 23 (1), 1-11, 2013 | 206 | 2013 |
| In Vivo RNAi Screen for BMI1 Targets Identifies TGF-β/BMP-ER Stress Pathways as Key Regulators of Neural-and Malignant Glioma-Stem Cell Homeostasis M Cesaroni, G Gargiulo, M Serresi, N de Vries, D Hulsman, ... Cancer cell 23 (5), 660-676, 2013 | 205 | 2013 |
| Integrator regulates transcriptional initiation and pause release following activation A Gardini, D Baillat, M Cesaroni, D Hu, JM Marinis, EJ Wagner, MA Lazar, ... Molecular cell 56 (1), 128-139, 2014 | 185 | 2014 |
| G9a is essential for epigenetic silencing of K+ channel genes in acute-to-chronic pain transition G Laumet, J Garriga, SR Chen, Y Zhang, DP Li, TM Smith, Y Dong, ... Nature neuroscience 18 (12), 1746-1755, 2015 | 179 | 2015 |
| Analysis of Myc-induced histone modifications on target chromatin F Martinato, M Cesaroni, B Amati, E Guccione PloS one 3 (11), e3650, 2008 | 170 | 2008 |
| Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53 S Licciulli, JL Avila, L Hanlon, S Troutman, M Cesaroni, S Kota, B Keith, ... Cancer research 73 (19), 5974-5984, 2013 | 129 | 2013 |
| Polycomb repressive complex 2 is a barrier to KRAS-driven inflammation and epithelial-mesenchymal transition in non-small-cell lung cancer M Serresi, G Gargiulo, N Proost, B Siteur, M Cesaroni, M Koppens, H Xie, ... Cancer cell 29 (1), 17-31, 2016 | 124 | 2016 |
| TET2 mutations affect non-CpG island DNA methylation at enhancers and transcription factor–binding sites in chronic myelomonocytic leukemia J Yamazaki, J Jelinek, Y Lu, M Cesaroni, J Madzo, F Neumann, R He, ... Cancer research 75 (14), 2833-2843, 2015 | 113 | 2015 |
| Human mutations in integrator complex subunits link transcriptome integrity to brain development R Oegema, D Baillat, R Schot, LM van Unen, A Brooks, SK Kia, ... PLoS genetics 13 (5), e1006809, 2017 | 88 | 2017 |
| RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas E Fagiani, G Giardina, L Luzi, M Cesaroni, M Quarto, M Capra, ... Cancer research 67 (7), 3064-3073, 2007 | 88 | 2007 |
| AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets A Gardini, M Cesaroni, L Luzi, AJ Okumura, JR Biggs, SP Minardi, ... PLoS genetics 4 (11), e1000275, 2008 | 84 | 2008 |
| Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell–mediated airway hyperreactivity H Maazi, H Banie, GRA Muench, N Patel, B Wang, I Sankaranarayanan, ... Journal of Allergy and Clinical Immunology 141 (3), 893-905. e6, 2018 | 77 | 2018 |
| Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival I Tempera, A De Leo, AV Kossenkov, M Cesaroni, H Song, N Dawany, ... Journal of virology 90 (1), 345-355, 2016 | 75 | 2016 |
| Prion‐like aggregation of mitochondrial antiviral signaling protein in lupus patients is associated with increased levels of type I interferon WH Shao, DH Shu, Y Zhen, B Hilliard, SO Priest, M Cesaroni, JPY Ting, ... Arthritis & rheumatology 68 (11), 2697-2707, 2016 | 70 | 2016 |
| Transcriptional selectivity of epigenetic therapy in cancer T Sato, M Cesaroni, W Chung, S Panjarian, A Tran, J Madzo, Y Okamoto, ... Cancer research 77 (2), 470-481, 2017 | 62 | 2017 |
| NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation G Gargiulo, S Levy, G Bucci, M Romanenghi, L Fornasari, KY Beeson, ... Developmental cell 16 (3), 466-481, 2009 | 62 | 2009 |
| Genome‐wide analysis reveals a role for BRCA 1 and PALB 2 in transcriptional co‐activation A Gardini, D Baillat, M Cesaroni, R Shiekhattar The EMBO journal 33 (8), 890-905, 2014 | 59 | 2014 |
